Literature DB >> 6112525

Haemostatic factors in human aortic intima.

E B Smith, E M Staples.   

Abstract

Accumulation of lipid in developing fibrous atherosclerotic plaques is associated with high concentrations of fibrin and accumulation of a tightly bound lipoprotein fraction that can be released by incubation with fibrinolytic enzymes, suggesting that fibrin may play a key role in lesion development. It is not known whether this fibrin represents incorporated mural thrombus or is produced in situ by clotting of the fibrinogen that is present in intima in high concentration. Immunoelectrophoresis was used to measure the concentrations of fibrinogen and components of the clotting system in human aortic intima and lesions, and in mural thrombi. In the lipid and fibrin rich plaque centres prothrombin concentration was almost twice that in normal intima, but concentrations of the thrombin inhibitors antithrombin III and alpha 2-macroglobulin fell, so that the molar ratios of inhibitor/prothrombin fell from 3:1 in normal intima to 1:1 in the plaque centre. In mural thrombi there was preferential sequestration of fibrinogen-like antigen and prothrombin. Distribution of factor-VIII-related antigen was highly unpredictable; in both normal intima and all types of intimal lesion substantial amounts were recovered from some samples, whereas none was recovered from others. The highest concentrations were found in samples free of endothelium from the deep layers of lesions. The results are compatible with the idea that fibrinogen may be converted to fibrin within lesions; once some fibrin has accumulated within the intima it seems to bind low-density lipoprotein and sequester fibrinogen and clotting factors, thereby producing a self-amplifying system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112525     DOI: 10.1016/s0140-6736(81)92346-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Fibrinogen/fibrin in atherogenesis.

Authors:  E B Smith; W D Thompson; L Crosbie; C M Stirk
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

3.  Thrombosis and ischaemic heart disease.

Authors:  T W Meade
Journal:  Br Heart J       Date:  1985-05

4.  Plasma fibrinogen--a major coronary risk factor.

Authors:  M C Stone; J M Thorp
Journal:  J R Coll Gen Pract       Date:  1985-12

5.  Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen.

Authors:  K Nakagami; O Shimazaki; R Sato; Y Komine; S Ohkuma; T Takano
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  Apolipoprotein (a) concentrations and susceptibility to coronary artery disease in patients with peripheral vascular disease.

Authors:  P Groves; A Rees; A Bishop; R Morgan; M Ruttley; N Lewis; I Lane; R Hall
Journal:  Br Heart J       Date:  1993-01

7.  Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study.

Authors:  Y Friedlander; Y Elkana; R Sinnreich; J D Kark
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

8.  Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas.

Authors:  R Valenzuela; J R Shainoff; P M DiBello; D A Urbanic; J M Anderson; G R Matsueda; B J Kudryk
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

9.  High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.

Authors:  K Ihnken; W Speiser; W Ruf; W Thiel; M Schlepper; G Müller-Berghaus
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

10.  Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin.

Authors:  T V Byzova; E F Plow
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.